Several studies on breast cancer have shown that miR-26a can inhibit cell proliferation, colony formation and migration, as well as promote apoptosis by regulating several carcinogenesis-related processes, including several mechanisms that involve the targeting of MCL-1, MTDH and EZH2 [42,43]. The gene discussed is MCL1; the disease is breast carcinoma.